Evidence map›Paper›PMID 37623799›Full record

ReviewMembranes2023

Recovery of Homogeneous Platinoid Catalysts from Pharmaceutical Media: Review on the Existing Treatments and the Perspectives of Membrane Processes.

Adrien Magne, Emilie Carretier, Lilivet Ubiera Ruiz, Thomas Clair, Morgane Le Hir, Philippe Moulin

Abstract readReview
In one paragraph

Review in Membranes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Adrien MagneAix Marseille Univ., CNRS, Centrale Marseille, M2P2 UMR 7340, Equipe Procédés Membranaires (EPM), Europole de l'Arbois, BP80, Pavillon Laennec, Hall C, 13545 Aix en Provence Cedex, France.ORCID 0000-0002-1021-3064
Emilie CarretierAix Marseille Univ., CNRS, Centrale Marseille, M2P2 UMR 7340, Equipe Procédés Membranaires (EPM), Europole de l'Arbois, BP80, Pavillon Laennec, Hall C, 13545 Aix en Provence Cedex, France.ORCID 0000-0001-5630-0975
Lilivet Ubiera RuizSanofi Chimie, Laboratoire Génie des Procédés 1, Process Engineering, Global Chemistry Manufacturing & Control (CMC), 45 Chemin de Mételine, 04200 Sisteron, France.
Thomas ClairSanofi Chimie, Laboratoire Génie des Procédés 1, Process Engineering, Global Chemistry Manufacturing & Control (CMC), 45 Chemin de Mételine, 04200 Sisteron, France.
Morgane Le HirSanofi Chimie, Laboratoire Génie des Procédés 1, Process Engineering, Global Chemistry Manufacturing & Control (CMC), 45 Chemin de Mételine, 04200 Sisteron, France.
Philippe MoulinAix Marseille Univ., CNRS, Centrale Marseille, M2P2 UMR 7340, Equipe Procédés Membranaires (EPM), Europole de l'Arbois, BP80, Pavillon Laennec, Hall C, 13545 Aix en Provence Cedex, France.ORCID 0000-0002-9585-0571

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Catalyst recovery is a major challenge for reaching the objectives of green chemistry for industry. Indeed, catalysts enable quick and selective syntheses with high reaction yields. This is especially the case for homogeneous platinoid catalysts which are almost indispensable for cross-coupling reactions often used by the pharmaceutical industry. However, they are based on scarce, expensive, and toxic resources. In addition, they are quite sensitive and degrade over time at the end of the reaction. Once degraded, their regeneration is complex and hazardous to implement. Working on their recovery could lead to highly effective catalytic chemistries while limiting the environmental and economic impacts of their one-time uses. This review aims to describe and compare conventional processes for metal removal while discussing their advantages and drawbacks considering the objective of homogeneous catalyst recovery. Most of them lead to difficulty recycling active catalysts due to their ability to only treat metal ions or to chelate catalysts without the possibility to reverse the mechanism. However, membrane processes seem to offer some perspectives with limiting degradations. While membranes are not systematically the best option for recycling homogeneous catalysts, current development might help improve the separation between pharmaceutical active ingredients and catalysts and enable their recycling.

Indexed as

homogenous catalystmembranesmetal recoveryorganic solventplatinoid

Identifiers

PMID37623799
PMCPMC10456598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.